What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases

作者: Véronique Tack , Zandra C. Deans , Nicola Wolstenholme , Simon Patton , Elisabeth M. C. Dequeker

DOI: 10.1002/HUMU.22975

关键词:

摘要: The Human Genome Variation Society (HGVS) recommendations provide standardized nomenclature for reporting variants. This should be encouraged in molecular pathology-both issuing diagnostic reports and correct data recording electronic databases. Many providers of external quality assessment (EQA) promote the use HGVS by scoring variant descriptions used EQA reports. study focuses on type impact errors. An was made EGFR gene four (European Pathology [ESP], European Molecular Genetics Quality Network [EMQN], United Kingdom National External Assessment Service Genetics, French national Gen&Tiss scheme) two distributions. Laboratories testing oncology biomarkers make different errors when describing Significant differences were observed regarding inclusion reference sequence: EMQN participants fewer compared to ESP (P-value = 0.015). analysis showed significant improvement over 2 years 0.016). Results demonstrate need according guidelines. Consequences using incorrect mutation are currently perceived as low many laboratories, but will rise with an increased reliance databases assist result analysis.

参考文章(19)
Shuji Ogino, Margaret L Gulley, Johan T den Dunnen, Robert B Wilson, Association for Molecular Pathology Training and Education Committee, Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. The Journal of Molecular Diagnostics. ,vol. 9, pp. 1- 6 ,(2007) , 10.2353/JMOLDX.2007.060081
D Fredman, Marianne Siegfried, Yan P Yuan, Peer Bork, Heikki Lehväslaiho, Anthony J Brookes, HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources Nucleic Acids Research. ,vol. 30, pp. 387- 391 ,(2002) , 10.1093/NAR/30.1.387
Frédérique Nowak, Jean-Charles Soria, Fabien Calvo, Tumour molecular profiling for deciding therapy-the French initiative. Nature Reviews Clinical Oncology. ,vol. 9, pp. 479- 486 ,(2012) , 10.1038/NRCLINONC.2012.42
Ourania Horaitis, Richard G. H. Cotton, The challenge of documenting mutation across the genome: the human genome variation society approach. Human Mutation. ,vol. 23, pp. 447- 452 ,(2004) , 10.1002/HUMU.20038
R G H Cotton, , O Horaitis, The HUGO Mutation Database Initiative Pharmacogenomics Journal. ,vol. 2, pp. 16- 19 ,(2002) , 10.1038/SJ.TPJ.6500070
S Patton, N Normanno, F Blackhall, S Murray, KM Kerr, M Dietel, M Filipits, S Benlloch, S Popat, R Stahel, E Thunnissen, None, Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer. ,vol. 111, pp. 413- 420 ,(2014) , 10.1038/BJC.2014.353
C.R. Mueller, U. Kristoffersson, D. Stoppa-Lyonnet, External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years Annals of Oncology. ,vol. 15, pp. 14- 17 ,(2004) , 10.1093/ANNONC/MDH652
Zandra C Deans, Neil Bilbe, Brendan O'Sullivan, Lazarus P Lazarou, David Gonzalez de Castro, Suzanne Parry, Andrew Dodson, Philippe Taniere, Caroline Clark, Rachel Butler, Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment Journal of Clinical Pathology. ,vol. 66, pp. 319- 325 ,(2013) , 10.1136/JCLINPATH-2012-201227
Lien Tembuyser, Véronique Tack, Karen Zwaenepoel, Patrick Pauwels, Keith Miller, Lukas Bubendorf, Keith Kerr, Ed Schuuring, Erik Thunnissen, Elisabeth M. C. Dequeker, The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization PLoS ONE. ,vol. 9, pp. e112159- ,(2014) , 10.1371/JOURNAL.PONE.0112159